Kicking off a holiday-shortened week for the markets, Jim Cramer and David Faber highlighted the latest vaccine news to lift stocks: AstraZeneca announced that its COVID-19 vaccine being developed in conjunction with Oxford University was up to 90 percent effective with no serious side effects in a clinical trial. The anchors explored the push to develop and ... Show More
May 1
SOTS 2nd Hour: Where Markets Stand, Apple's Earnings Gains, & Is It Finally Time To Touch Software? 5/1/26
A huge week for markets - spanning earnings, a Fed decision, and stocks hitting fresh highs: Carl Quintanilla and Sara Eisen broke down where things stand after all the reports before discussing whether the rally has legs with longtime market veteran Jeremy Siegel. Plus: a deep-d ... Show More
43m 3s
May 1
Apple Jumps on Q2 Beat, Markets Playbook for May, Big Oil Earnings Beats 5/1/26
Carl Quintanilla and Jim Cramer led off the show with Apple shares jumping on a Q2 beat and revenue guidance. The discussion also focused on Apple's future, with John Ternus set to succeed Tim Cook as CEO in September. The anchors also explored what to expect from the markets in ... Show More
42m 12s
Jan 2025
AI, vaccine distrust, and the future of healthcare: Novartis CEO
Can science prevail against this more turbulent backdrop of the Trump administration? Yahoo Finance executive editor Brian Sozzi talks at length with Novartis CEO Vas Narasimhan. Narasimhan has led the drug giant since 2018, doing deals that have expanded the company’s pipeline i ... Show More
25m 45s